Latest

Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆

Updated 18 Aug 2026 · ClinicalTrials.gov

Relapsing Multiple Sclerosis Trials in the UK

← All UK trials

The most recently updated industry-sponsored clinical trials recruiting across the United Kingdom — searchable by condition, sponsor, phase and city. Refreshed daily from the ClinicalTrials.gov registry.

0

Recruiting now

3

Studies tracked

124

Cities with sites

Active Phase 3

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)

Relapsing Multiple Sclerosis
Novartis Pharmaceuticals · started 2021-12-13

📍 Inverness · Canterbury

NCT05156281 on ClinicalTrials.gov ↗

Active Phase 3

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

Relapsing Multiple Sclerosis
Novartis Pharmaceuticals · started 2021-12-16

📍 Westbruy on Trym · Winchester · Glasgow

NCT05147220 on ClinicalTrials.gov ↗

Active Phase 3

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
Sanofi · started 2024-04-16

📍 Exeter · Kent · London · Swansea · Nottingham

NCT06372145 on ClinicalTrials.gov ↗

No trials match your search.

Browse by city

London · 111 Manchester · 46 Glasgow · 33 Cambridge · 27 Oxford · 26 Birmingham · 25 Sutton · 19 Cardiff · 18 Leicester · 17 Bristol · 16 Sheffield · 15 Edinburgh · 13 Liverpool · 11 Nottingham · 11 Newcastle upon Tyne · 10 Leeds · 10

Browse by condition

Non-small Cell Lung Cancer · 4 Ulcerative Colitis · 3 Solid Tumors · 3 Heart Failure · 3 Relapsing Multiple Sclerosis · 3 Breast Cancer · 3 Metastatic Colorectal Cancer · 3 Obesity · 3 Ovarian Cancer · 3 Multiple Myeloma · 3 Hematologic Malignancies · 2 PIK3CA-related Overgrowth Spectru… · 2 Metastatic Castration-resistant P… · 2 Healthy Volunteers · 2 Small Cell Lung Cancer (SCLC) · 2 Asthma · 2

Cite this page

Priya Life Science (2026). Clinical Trials in the UK Tracker. Available at: https://priyalifescience.com/clinical-trials-uk/condition/relapsing-multiple-sclerosis (Accessed: 19 August 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one UK site, most recently updated first, refreshed daily. This is a curated slice of the registry, not every UK trial; UK studies may also be registered on ISRCTN. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our UK Pharma Salary Guide, or see our Ireland, EU and USA trackers.